Home LiteratureArticle Details
PMID: 11254633 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.

Infection and immunity ·Vol. 69 ·No. 4 ·2001-04-00 ·Pages 2666-74

Chackerian AA, Perera TV, Behar SM

Abstract

The human immune system efficiently limits the replication of Mycobacterium tuberculosis in most infected individuals. Only 5 to 10% of infected people develop clinical tuberculosis, a sign of the inability of the immune system to control the infection. We have studied the C3H/HeJ (C3H) and C57BL/6 (B6) inbred mouse strains, which differ in their susceptibility to tuberculosis, in order to ascertain the immunological determinants of a successful immune response against M. tuberculosis and to establish a system to identify genes that influence susceptibility to tuberculosis. We found that the resistant B6 mice were able to control infection in both the lung and spleen, while susceptible C3H mice were incapable of limiting bacteria growth, especially in the lung, and succumbed to infection within 4 weeks. We determined that the susceptibility of C3H mice was independent of the Toll-like receptor 4 (tlr4) genetic locus and allelic major histocompatibility complex differences. Although the splenic immune responses were similar in the two mouse strains, the local immune responses in the lungs of the infected mice differed greatly. The pulmonary immune response in resistant B6 mice was characterized by an early influx of both CD4+ and CD8+ lymphocytes that produced gamma interferon (IFN-gamma). In contrast, the immune response of C3H mice in the lung was characterized by a delayed and decreased influx of lymphocytes, which produced little IFN-gamma. These results suggest an important role for the early appearance of IFN-gamma-producing lymphocytes in the lung in resistance to infection with M. tuberculosis.

MeSH Terms
Animals CD4-Positive T-Lymphocytes/immunology Female H-2 Antigens/genetics Haplotypes Interferon-gamma/biosynthesis Interleukin-12/physiology Lung/immunology Mice Mice, Inbred C3H Mice, Inbred C57BL Spleen/immunology Tuberculosis, Pulmonary/immunology
Chemicals
H-2 Antigens Interleukin-12 Interferon-gamma
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Chackerian A A
Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA.
Perera T V
Behar S M
References (41)
41 references, click to expand
  1. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
    J Clin Invest. 1997 Dec 1;100(11):2658-64 PMID: 9389728
  2. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
    J Immunol. 1999 Oct 1;163(7):3920-7 PMID: 10490993
  3. The immunogenetics of human infectious diseases.
    Annu Rev Immunol. 1998;16:593-617 PMID: 9597143
  4. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.
    Science. 1998 May 29;280(5368):1432-5 PMID: 9603732
  5. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype.
    Immunology. 1998 Feb;93(2):270-4 PMID: 9616378
  6. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice.
    J Immunol. 1998 Jun 15;160(12):6101-11 PMID: 9637527
  7. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification.
    J Exp Med. 1998 Jul 20;188(2):351-64 PMID: 9670047
  8. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis.
    Clin Exp Immunol. 1998 Jul;113(1):55-8 PMID: 9697983
  9. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
    Science. 1998 Dec 11;282(5396):2085-8 PMID: 9851930
  10. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.
    J Clin Invest. 1998 Dec 15;102(12):2035-40 PMID: 9854038
  11. Susceptibility to tuberculosis as a complex genetic trait: analysis using recombinant congenic strains of mice.
    Novartis Found Symp. 1998;217:120-31; discussion 132-7 PMID: 9949805
  12. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
    Nature. 1999 Oct 21;401(6755):811-5 PMID: 10548109
  13. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors.
    J Immunol. 1999 Dec 15;163(12):6748-55 PMID: 10586073
  14. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
    Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14459-63 PMID: 10588727
  15. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
    J Clin Invest. 2000 Feb;105(4):497-504 PMID: 10683379
  16. Tuberculosis in twins: a re-analysis of the Prophit survey.
    Am Rev Respir Dis. 1978 Apr;117(4):621-4 PMID: 565607
  17. Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
    Clin Exp Immunol. 1989 Jun;76(3):458-62 PMID: 2502336
  18. Genetic influences on the immune repertoire following tuberculous infection in mice.
    Immunology. 1990 Sep;71(1):113-9 PMID: 2120127
  19. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
    Clin Exp Immunol. 1991 Mar;83(3):466-71 PMID: 1900745
  20. T-cell immune responses in Mycobacterium avium-infected mice.
    Infect Immun. 1992 Jan;60(1):150-3 PMID: 1729179
  21. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice.
    Immunology. 1992 May;76(1):129-32 PMID: 1628890
  22. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg.
    Cell. 1993 May 7;73(3):469-85 PMID: 8490962
  23. Disseminated tuberculosis in interferon gamma gene-disrupted mice.
    J Exp Med. 1993 Dec 1;178(6):2243-7 PMID: 8245795
  24. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
    J Exp Med. 1993 Dec 1;178(6):2249-54 PMID: 7504064
  25. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
    Immunology. 1995 Mar;84(3):423-32 PMID: 7751026
  26. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.
    Immunity. 1995 Jun;2(6):561-72 PMID: 7540941
  27. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection.
    J Immunol. 1995 Sep 1;155(5):2515-24 PMID: 7650381
  28. Mice that carry the resistance allele of the Bcg gene (Bcgr) develop a superior capacity to stabilize bacille Calmette-Guerin (BCG) infection in their lungs and spleen over a protracted period in the absence of specific immunity.
    Clin Exp Immunol. 1996 Apr;104(1):44-7 PMID: 8603532
  29. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.
    J Exp Med. 1996 Mar 1;183(3):1045-51 PMID: 8642246
  30. The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele.
    Infect Immun. 1996 Aug;64(8):2923-9 PMID: 8757814
  31. The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis.
    Immunology. 1996 Aug;88(4):479-81 PMID: 8881745
  32. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.
    N Engl J Med. 1996 Dec 26;335(26):1941-9 PMID: 8960473
  33. The Bcg gene (Nramp1) does not determine resistance of mice to virulent Mycobacterium tuberculosis.
    Ann N Y Acad Sci. 1996 Oct 25;797:257-9 PMID: 8993372
  34. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.
    J Exp Med. 1997 Jul 7;186(1):39-45 PMID: 9206995
  35. Lethal tuberculosis in interleukin-6-deficient mutant mice.
    Infect Immun. 1997 Nov;65(11):4843-9 PMID: 9353074
  36. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene.
    J Infect Dis. 1999 Mar;179(3):721-4 PMID: 9952386
  37. Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism.
    J Immunol. 1999 Feb 1;162(3):1339-47 PMID: 9973388
  38. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis.
    J Exp Med. 1999 Jun 21;189(12):1863-74 PMID: 10377182
  39. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.
    J Exp Med. 1999 Jun 21;189(12):1973-80 PMID: 10377193
  40. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
    Science. 1999 Jul 30;285(5428):732-6 PMID: 10426995
  41. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans.
    N Engl J Med. 1998 Mar 5;338(10):640-4 PMID: 9486992
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2001-04-00
Pages
2666-74
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC98205
Subset
IM
Grants
NHLBI NIH HHS · R01 HL064540 · United States
NIAID NIH HHS · T32 AI007306 · United States
NHLBI NIH HHS · HL64540 · United States
NIAID NIH HHS · T32 AI 07306 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com